Birdwatch Note Rating
2023-08-20 10:12:52 UTC - HELPFUL
Rated by Participant: D8642179B82826B193E92B1B1C59AB7E06F39463C4AD55F752528D66FB20FEFD
Participant Details
Original Note:
NNN. Personal opinion. To date, at least 3 pharmacovigilance analyses suggest potential kidney damage associated with remdesivir use. https://pubmed.ncbi.nlm.nih.gov/33340409/ https://pubmed.ncbi.nlm.nih.gov/34787281/ https://pubmed.ncbi.nlm.nih.gov/35401177/ According to the FDA, one of the most common adverse reactions is increased ALT, associated with liver injury or disease. https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/214787s019lbl.pdf
All Note Details